Nymox Pharmaceutical Corp NYMX shares are trading lower by 29.6% at $1.33 after the company announced a common stock offering of 3.03 million shares at $1.65 per share.
Nymox says the closing of the offering is expected to occur on or about March 22, 2022, subject to the satisfaction of customary closing conditions. The company intends to use the proceeds for general corporate purposes, including working capital.
See Also: Why FedEx Shares Are Sliding Today
Nymox Pharmaceutical is a biopharmaceutical company. The firm and its subsidiaries specialize in the research and development of drugs and diagnostic products for the aging population.
Nymox Pharmaceutical has a 52-week high of $2.87 and a 52-week low of $0.94.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
